Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Non-Current Deferred Tax Liability (2016 - 2018)

Medifast's Non-Current Deferred Tax Liability history spans 9 years, with the latest figure at -$208000.0 for Q4 2018.

  • For Q4 2018, Non-Current Deferred Tax Liability fell 200.0% year-over-year to -$208000.0; the TTM value through Dec 2018 reached -$208000.0, down 200.0%, while the annual FY2018 figure was -$208000.0, 200.0% down from the prior year.
  • Non-Current Deferred Tax Liability reached -$208000.0 in Q4 2018 per MED's latest filing, down from -$16000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $6.6 million in Q1 2014 to a low of -$208000.0 in Q4 2018.
  • Average Non-Current Deferred Tax Liability over 5 years is $3.2 million, with a median of $3.7 million recorded in 2015.
  • Peak YoY movement for Non-Current Deferred Tax Liability: grew 7.61% in 2015, then plummeted 200.0% in 2018.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $5.5 million in 2014, then crashed by 32.96% to $3.7 million in 2015, then plummeted by 78.84% to $779000.0 in 2016, then plummeted by 73.3% to $208000.0 in 2017, then tumbled by 200.0% to -$208000.0 in 2018.
  • Per Business Quant, the three most recent readings for MED's Non-Current Deferred Tax Liability are -$208000.0 (Q4 2018), -$16000.0 (Q1 2018), and $208000.0 (Q4 2017).